Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials.

Galvano A, Scaturro D, Badalamenti G, Incorvaia L, Rizzo S, Castellana L, Cusenza S, Cutaia S, Santini D, Guadagni F, Roselli M, Gori S, Latteri MA, Bazan V, Giulia LM, Russo A.

J Bone Oncol. 2019 Jul 16;18:100252. doi: 10.1016/j.jbo.2019.100252. eCollection 2019 Oct. Review.

2.

CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.

Arriga R, Caratelli S, Lanzilli G, Ottaviani A, Cenciarelli C, Sconocchia T, Spagnoli GC, Iezzi G, Roselli M, Lauro D, Coppola A, Dotti G, Ferrone S, Sconocchia G.

Int J Cancer. 2019 Aug 9. doi: 10.1002/ijc.32618. [Epub ahead of print]

PMID:
31396956
3.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

Int J Cancer. 2019 Jul 22. doi: 10.1002/ijc.32583. [Epub ahead of print]

PMID:
31330065
4.

Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes.

Marei HE, Althani A, Caceci T, Arriga R, Sconocchia T, Ottaviani A, Lanzilli G, Roselli M, Caratelli S, Cenciarelli C, Sconocchia G.

Biochem Pharmacol. 2019 Aug;166:335-346. doi: 10.1016/j.bcp.2019.06.002. Epub 2019 Jun 6. Review.

PMID:
31176617
5.

Supplementation with Bifidobacterium longum Bar33 and Lactobacillus helveticus Bar13 mixture improves immunity in elderly humans (over 75 years) and aged mice.

Finamore A, Roselli M, Donini L, Brasili DE, Rami R, Carnevali P, Mistura L, Pinto A, Giusti A, Mengheri E.

Nutrition. 2019 Jul - Aug;63-64:184-192. doi: 10.1016/j.nut.2019.02.005. Epub 2019 Feb 18.

PMID:
31029046
6.

Breast Cancer Prognosis Using a Machine Learning Approach.

Ferroni P, Zanzotto FM, Riondino S, Scarpato N, Guadagni F, Roselli M.

Cancers (Basel). 2019 Mar 7;11(3). pii: E328. doi: 10.3390/cancers11030328.

7.

Precision medicine in the ageing world: The role of biospecimen sciences.

Riondino S, Ferroni P, Roselli M, Guadagni F.

Int J Biol Markers. 2019 Mar;34(1):3-5. doi: 10.1177/1724600818816995. Epub 2019 Mar 11. No abstract available.

PMID:
30852947
8.

The Foodborne Strain Lactobacillus fermentum MBC2 Triggers pept-1-Dependent Pro-Longevity Effects in Caenorhabditis elegans.

Schifano E, Zinno P, Guantario B, Roselli M, Marcoccia S, Devirgiliis C, Uccelletti D.

Microorganisms. 2019 Feb 7;7(2). pii: E45. doi: 10.3390/microorganisms7020045.

9.

Leveraging marginal structural modeling with Cox regression to assess the survival benefit of accepting vs declining kidney allograft offers.

Cohen JB, Potluri V, Porrett PM, Chen R, Roselli M, Shults J, Sawinski DL, Reese PP.

Am J Transplant. 2019 Jul;19(7):1999-2008. doi: 10.1111/ajt.15290. Epub 2019 Mar 2.

PMID:
30725536
10.

Supplementation with dairy matrices impacts on homocysteine levels and gut microbiota composition of hyperhomocysteinemic mice.

Zinno P, Motta V, Guantario B, Natella F, Roselli M, Bello C, Comitato R, Carminati D, Tidona F, Meucci A, Aiello P, Perozzi G, Virgili F, Trevisi P, Canali R, Devirgiliis C.

Eur J Nutr. 2019 Jan 30. doi: 10.1007/s00394-019-01911-y. [Epub ahead of print]

PMID:
30701305
11.

Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models.

Riondino S, Ferroni P, Zanzotto FM, Roselli M, Guadagni F.

Cancers (Basel). 2019 Jan 15;11(1). pii: E95. doi: 10.3390/cancers11010095. Review.

12.

Canine Trypanosoma cruzi infection in the Bolivian Chaco.

Gabrielli S, Spinicci M, Macchioni F, Rojo D, Totino V, Rojas P, Roselli M, Gamboa H, Cancrini G, Bartoloni A.

Parasit Vectors. 2018 Dec 12;11(1):632. doi: 10.1186/s13071-018-3247-0.

13.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.

Pizzuti L, Giordano A, Michelotti A, Mazzotta M, Natoli C, Gamucci T, De Angelis C, Landucci E, Diodati L, Iezzi L, Mentuccia L, Fabbri A, Barba M, Sanguineti G, Marchetti P, Tomao S, Mariani L, Paris I, Lorusso V, Vallarelli S, Cassano A, Airoldi F, Orlandi A, Moscetti L, Sergi D, Sarobba MG, Tonini G, Santini D, Sini V, Veltri E, Vaccaro A, Ferrari L, De Tursi M, Tinari N, Grassadonia A, Greco F, Botticelli A, La Verde N, Zamagni C, Rubino D, Cortesi E, Magri V, Pomati G, Scagnoli S, Capomolla E, Kayal R, Scinto AF, Corsi D, Cazzaniga M, Laudadio L, Forciniti S, Mancini M, Carbognin L, Seminara P, Barni S, Samaritani R, Roselli M, Portarena I, Russo A, Ficorella C, Cannita K, Carpano S, Pistelli M, Berardi R, De Maria R, Sperduti I, Ciliberto G, Vici P.

J Cell Physiol. 2019 Jun;234(6):7708-7717. doi: 10.1002/jcp.27832. Epub 2018 Dec 10.

PMID:
30536609
14.

Chemotherapy in Patients with Hereditary Angioedema.

Morelli C, Formica V, Pellicori S, Menghi A, Guarino MD, Perricone R, Roselli M.

Anticancer Res. 2018 Dec;38(12):6801-6807. doi: 10.21873/anticanres.13052.

PMID:
30504393
15.

Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia.

Lucchetti J, Formica V, Giuliano G, Coletta D, Gargano L, Morosetti D, Sileri P, Palmieri G, Roselli M.

Anticancer Res. 2018 Nov;38(11):6561-6564. doi: 10.21873/anticanres.13022.

PMID:
30396986
16.

Cancer Patients in the Emergency Department: A "Nightmare" that Might Become a Virtuous Clinical Pathway.

Legramante JM, Pellicori S, Magrini A, Frittelli T, Formica V, Roselli M.

Anticancer Res. 2018 Nov;38(11):6387-6391. doi: 10.21873/anticanres.12998.

PMID:
30396962
17.

Hymenolepis nana-An Emerging Intestinal Parasite Associated with Anemia in School Children from the Bolivian Chaco.

Spinicci M, Macchioni F, Gabrielli S, Rojo D, Gamboa H, Villagrán AL, Vallejos Y, Strohmeyer M, Roselli M, Cancrini G, Olliaro P, Montresor A, Bartoloni A.

Am J Trop Med Hyg. 2018 Dec;99(6):1598-1601. doi: 10.4269/ajtmh.18-0397.

PMID:
30298806
18.

Artificial intelligence for cancer-associated thrombosis risk assessment.

Ferroni P, Roselli M, Zanzotto FM, Guadagni F.

Lancet Haematol. 2018 Sep;5(9):e391. doi: 10.1016/S2352-3026(18)30111-X. No abstract available.

PMID:
30172343
19.

Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco.

Bartoloni A, Remoli ME, Farchi F, Zammarchi L, Fortuna C, Benedetti E, Ciufolini MG, Macchioni F, Rojas P, Lara Y, Padilla C, Roselli M, Mantengoli E, Mantella A, Tolari F, Paredes GA, Monasterio J, Valdarchi C, Venturi G, Rezza G.

J Med Virol. 2019 Jan;91(1):146-150. doi: 10.1002/jmv.25283. Epub 2018 Sep 7.

PMID:
30118540
20.

Prognostic Significance of Neutrophil-to-lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer.

Ferroni P, Roselli M, Buonomo OC, Spila A, Portarena I, Laudisi A, Valente MG, Pirillo SP, Fortunato L, Costarelli L, Cavaliere F, Guadagni F.

Anticancer Res. 2018 Aug;38(8):4705-4712. doi: 10.21873/anticanres.12777.

PMID:
30061239
21.

Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?

Formica V, Zaniboni A, Loupakis F, Roselli M.

Int J Cancer. 2018 Nov 15;143(10):2342-2350. doi: 10.1002/ijc.31616. Epub 2018 Aug 11. Review.

PMID:
29873066
22.

Issues and promises of bevacizumab in prostate cancer treatment.

Cereda V, Formica V, Roselli M.

Expert Opin Biol Ther. 2018 Jun;18(6):707-717. doi: 10.1080/14712598.2018.1479737. Epub 2018 May 30. Review.

PMID:
29781343
23.

Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt.

Formica V, Benassi M, Del Vecchio Blanco G, Doldo E, Martano L, Portarena I, Nardecchia A, Lucchetti J, Morelli C, Giudice E, Rossi P, Anselmo A, Sileri P, Sica G, Orlandi A, Santoni R, Roselli M.

Med Oncol. 2018 May 2;35(6):83. doi: 10.1007/s12032-018-1141-4.

PMID:
29721745
24.

Scaling down of a deworming programme among school-age children after a thirty-year successful intervention in the Bolivian Chaco.

Spinicci M, Macchioni F, Rojo D, Gamboa H, Villagrán AL, Vallejos Y, Strohmeyer M, Roselli M, Gabrielli S, Cancrini G, Monasterio J, Castellanos P, Paredes GA, Maury S, Zárate A, Rocabado R, Olliaro P, Montresor A, Bartoloni A.

Trop Med Int Health. 2018 Jun;23(6):616-621. doi: 10.1111/tmi.13058. Epub 2018 May 2.

25.

In Vitro and in Vivo Selection of Potentially Probiotic Lactobacilli From Nocellara del Belice Table Olives.

Guantario B, Zinno P, Schifano E, Roselli M, Perozzi G, Palleschi C, Uccelletti D, Devirgiliis C.

Front Microbiol. 2018 Mar 28;9:595. doi: 10.3389/fmicb.2018.00595. eCollection 2018.

26.

Seroprevalence of Hepatitis A Virus, Hepatitis E Virus, and Helicobacter pylori in Rural Communities of the Bolivian Chaco, 2013.

Campolmi I, Spinicci M, Mayaregua DR, Barahona HG, Mantella A, Lara Y, Roselli M, Strohmeyer M, Corti G, Tolari F, Pinckert JM, Dalton HR, Bartoloni A.

Am J Trop Med Hyg. 2018 May;98(5):1275-1280. doi: 10.4269/ajtmh.17-0747. Epub 2018 Mar 22.

27.

Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?

Franzese O, Battaini F, Graziani G, Tentori L, Barbaccia ML, Aquino A, Roselli M, Fuggetta MP, Bonmassar E, Torino F.

Pharmacol Res. 2018 May;131:1-6. doi: 10.1016/j.phrs.2018.03.005. Epub 2018 Mar 9. Review.

PMID:
29530602
28.

Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer.

Formica V, Ionta MT, Massidda B, Vessia G, Maiorino L, Casaretti R, Natale D, Barberis G, Filippelli G, Greco E, Blasi L, Mancarella S, Russo A, Barbato E, Lullo LD, Roselli M.

Oncotarget. 2017 Dec 17;9(2):2876-2886. doi: 10.18632/oncotarget.23355. eCollection 2018 Jan 5.

29.

Validation of a Machine Learning Approach for Venous Thromboembolism Risk Prediction in Oncology.

Ferroni P, Zanzotto FM, Scarpato N, Riondino S, Guadagni F, Roselli M.

Dis Markers. 2017;2017:8781379. doi: 10.1155/2017/8781379. Epub 2017 Sep 17.

30.

Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis.

Grenga I, Donahue RN, Gargulak ML, Lepone LM, Roselli M, Bilusic M, Schlom J.

Urol Oncol. 2018 Mar;36(3):93.e1-93.e11. doi: 10.1016/j.urolonc.2017.09.027. Epub 2017 Nov 2.

31.

Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition.

Roselli M, Devirgiliis C, Zinno P, Guantario B, Finamore A, Rami R, Perozzi G.

Genes Nutr. 2017 Oct 4;12:25. doi: 10.1186/s12263-017-0583-1. eCollection 2017.

32.

Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987-2013) in the absence of disease-specific control measures.

Spinicci M, Macchioni F, Mantella A, Gabrielli S, Roselli M, Rojo Mayaregua D, Monasterio Pinckert J, Gamboa Barahona H, Paredes GA, Halkyer P, Cancrini G, Olliaro P, Montresor A, Bartoloni A.

Trop Med Int Health. 2017 Nov;22(11):1457-1462. doi: 10.1111/tmi.12977. Epub 2017 Oct 12.

33.

Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.

Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, Spila A, D'Alessandro R, Della-Morte D, Ferroni P, Roselli M.

World J Gastroenterol. 2017 Jul 28;23(28):5187-5195. doi: 10.3748/wjg.v23.i28.5187.

34.

Sex-Genetic Interaction in the Risk for Cerebrovascular Disease.

Pastore D, Pacifici F, Capuani B, Palmirotta R, Dong C, Coppola A, Abete P, Roselli M, Sbraccia P, Guadagni F, Lauro D, Rundek T, Della-Morte D.

Curr Med Chem. 2017;24(24):2687-2699. doi: 10.2174/0929867324666170417100318. Review.

PMID:
28413964
35.

Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.

Franzese O, Torino F, Fuggetta MP, Aquino A, Roselli M, Bonmassar E, Giuliani A, D'Atri S.

Oncotarget. 2017 Jun 20;8(25):41641-41669. doi: 10.18632/oncotarget.16335. Review.

36.

Biological and predictive role of ERCC1 polymorphisms in cancer.

Formica V, Doldo E, Antonetti FR, Nardecchia A, Ferroni P, Riondino S, Morelli C, Arkenau HT, Guadagni F, Orlandi A, Roselli M.

Crit Rev Oncol Hematol. 2017 Mar;111:133-143. doi: 10.1016/j.critrevonc.2017.01.016. Epub 2017 Jan 28. Review.

PMID:
28259288
37.

Anti-Angiogenic Drugs, Vascular Toxicity and Thromboembolism in Solid Cancer.

Riondino S, Del Monte G, Fratangeli F, Guadagni F, Roselli M, Ferroni P.

Cardiovasc Hematol Agents Med Chem. 2017;15(1):3-16. doi: 10.2174/1871525715666170127101605. Review.

PMID:
28137223
38.

Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer.

Vergati M, Krasniqi E, Monte GD, Riondino S, Vallone D, Guadagni F, Ferroni P, Roselli M.

Curr Med Chem. 2017;24(12):1170-1185. doi: 10.2174/0929867324666170116122915. Review.

PMID:
28093985
39.

Prognostic value of glycated hemoglobin in colorectal cancer.

Ferroni P, Formica V, Della-Morte D, Lucchetti J, Spila A, D'Alessandro R, Riondino S, Guadagni F, Roselli M.

World J Gastroenterol. 2016 Dec 7;22(45):9984-9993. doi: 10.3748/wjg.v22.i45.9984.

40.

Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care).

Zagonel V, Franciosi V, Brunello A, Biasco G, Broglia C, Cattaneo D, Cavanna L, Corsi D, Farina G, Fioretto L, Gamucci T, Lanzetta G, Magarotto R, Maltoni M, Marchetti P, Massa E, Mastromauro C, Melotti B, Meriggi F, Nacci A, Pavese I, Piva E, Quirino M, Roselli M, Sacco C, Tonini G, Trentin L, Ucci G, Labianca R, Gori S, Pinto C, Cascinu S; AIOM Simultaneous and Continuous Care (SCC), Task Force: ESMO Italian DCs.

Tumori. 2017 Jan 21;103(1):9-14. doi: 10.5301/tj.5000593. Epub 2016 Dec 19. Review.

PMID:
28009422
41.

Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.

Formica V, Morelli C, Ferroni P, Nardecchia A, Tesauro M, Pellicori S, Cereda V, Russo A, Riondino S, Guadagni F, Roselli M.

Cancer Biomark. 2016 Sep 26;17(3):335-345.

PMID:
27434293
42.

Oxidant stress as a major determinant of platelet activation in invasive breast cancer.

Ferroni P, Santilli F, Cavaliere F, Simeone P, Costarelli L, Liani R, Tripaldi R, Riondino S, Roselli M, Davi G, Guadagni F.

Int J Cancer. 2017 Feb 1;140(3):696-704. doi: 10.1002/ijc.30488. Epub 2016 Nov 7.

43.

Gender Differences in Cancer-associated Venous Thromboembolism.

Riondino S, Guadagni F, Formica V, Ferroni P, Roselli M.

Curr Med Chem. 2017;24(24):2589-2601. doi: 10.2174/0929867323666161018144505. Review.

PMID:
27758714
44.

Intestinal parasitic infections and associated epidemiological drivers in two rural communities of the Bolivian Chaco.

Macchioni F, Segundo H, Totino V, Gabrielli S, Rojas P, Roselli M, Paredes GA, Masana M, Bartoloni A, Cancrini G.

J Infect Dev Ctries. 2016 Sep 30;10(9):1012-1019. doi: 10.3855/jidc.7657.

46.

Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons.

Sini V, Cassano A, Corsi D, De Laurentiis M, Gamucci T, Mauri M, Naso G, Roselli M, Ruggeri EM, Tonini G, Vici P, Zampa G, Marchetti P.

Tumori. 2016 Oct 13;102(5):472-480. doi: 10.5301/tj.5000555. Epub 2016 Aug 23. Review.

PMID:
27647231
47.

The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy.

Roselli M, Formica V, Cereda V, Jochems C, Richards J, Grenga I, Orlandi A, Ferroni P, Guadagni F, Schlom J.

Oncoimmunology. 2016 May 19;5(7):e1188243. doi: 10.1080/2162402X.2016.1188243. eCollection 2016 Jul.

48.

Relevance of computed tomography and magnetic resonance imaging for penile metastasis after prostatectomy: uncommon case report and brief review of the literature.

Fiaschetti V, Liberto V, Claroni G, Loreni G, Formica V, Roselli M, Mauriello A, Floris R.

Radiol Case Rep. 2016 May 14;11(3):255-9. doi: 10.1016/j.radcr.2016.04.003. eCollection 2016 Sep.

49.

Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.

Hamilton DH, Roselli M, Ferroni P, Costarelli L, Cavaliere F, Taffuri M, Palena C, Guadagni F.

Endocr Relat Cancer. 2016 Oct;23(10):783-796. doi: 10.1530/ERC-16-0037.

50.

Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients.

Ferroni P, Zanzotto FM, Scarpato N, Riondino S, Nanni U, Roselli M, Guadagni F.

Med Decis Making. 2017 Feb;37(2):234-242. doi: 10.1177/0272989X16662654. Epub 2016 Aug 19.

PMID:
27491558

Supplemental Content

Loading ...
Support Center